연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
1437. Synergistic killing effect of imatinib and simvastatin on imatinib-resistant chronic myelogenous leukemia cells.
Oh B1, Kim TY, Min HJ, Kim M, Kang MS, Huh JY, Kim Y, Lee DS.
Anticancer Drugs. 2013 Jan;24(1):20-31. doi: 10.1097/CAD.0b013e32835a0fbd.
Link
1436. In vivo bioluminescence reporter gene imaging for the activation of neuronal differentiation induced by the neuronal activator neurogenin 1 (Ngn1) in neuronal precursor cells.
Oh HJ1, Hwang do W, Youn H, Lee DS.
Eur J Nucl Med Mol Imaging. 2013 Oct;40(10):1607-17. doi: 10.1007/s00259-013-2457-0. Epub 2013 Jun 11.
Link
1435. Effect of complementary and alternative medicine on the survival and health-related quality of life among terminally ill cancer patients: a prospective cohort study.
Yun YH1,?Lee MK,?Park SM,?Kim YA,?Lee WJ,?Lee KS,?Choi JS,?Jung KH,?Do YR,?Kim SY,?Heo DS,?Kim HT,?Park SR.
Ann Oncol.?2013 Feb;24(2):489-94. doi: 10.1093/annonc/mds469. Epub 2012 Oct 30.
Link
1434. Factors associated with depression in disease-free stomach cancer survivors.
Han KH1,?Hwang IC,?Kim S,?Bae JM,?Kim YW,?Ryu KW,?Lee JH,?Noh JH,?Sohn TS,?Shin DW,?Yun YH.
J Pain Symptom Manage.?2013 Oct;46(4):511-22. doi: 10.1016/j.jpainsymman.2012.10.234. Epub 2013 Mar 13.
Link
1433. Suicide ideation in stomach cancer survivors and possible risk factors.
Choi YN1,?Kim YA,?Yun YH,?Kim S,?Bae JM,?Kim YW,?Ryu KW,?Lee JH,?Noh JH,?Sohn TS.
Support Care Cancer.?2014 Feb;22(2):331-7. doi: 10.1007/s00520-013-1975-4. Epub 2013 Sep 21.
Link
1432. Recombinant human epidermal growth factor on oral mucositis induced by intensive chemotherapy with stem cell transplantation.
Kim KI, Kim JW, Lee HJ, Kim BS, Bang SM, Kim I, Oh JM, Yoon SS, Lee JS, Park S, Kim BK.
Am J Hematol. 2013 Feb;88(2):107-12. doi: 10.1002/ajh.23359. Epub 2012 Dec 8.
Link
1431. Antitumor activity of saracatinib (AZD0530), a c-Src/Abl kinase inhibitor, alone or in combination with chemotherapeutic agents in gastric cancer.
Nam HJ1, Im SA, Oh DY, Elvin P, Kim HP, Yoon YK, Min A, Song SH, Han SW, Kim TY, Bang YJ.
Mol Cancer Ther. 2013 Jan;12(1):16-26. doi: 10.1158/1535-7163.MCT-12-0109. Epub 2012 Nov 9.
Link
1430. OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells.OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells.
Kim MJ1, Nam HJ, Kim HP, Han SW, Im SA, Kim TY, Oh DY, Bang YJ.
Cancer Lett. 2013 Jul 10;335(1):145-52. doi: 10.1016/j.canlet.2013.02.010. Epub 2013 Feb 10.
Link
1429. The Impact of Body Mass Index Dynamics on Survival of Patients With Advanced Pancreatic Cancer Receiving Chemotherapy.
Choi Y1, Kim TY, Lee KH, Han SW, Oh DY, Im SA, Kim TY, Bang YJ.
J Pain Symptom Manage. 2013 Dec 6. pii: S0885-3924(13)00612-X. doi: 10.1016/j.jpainsymman.2013.08.017. [Epub ahead of print]
Link
1428. Outcomes of minimally invasive surgery for early gastric cancer are comparable with those for open surgery: analysis of 1,013 minimally invasive surgeries at a single institution.
Oh SY1, Kwon S, Lee KG, Suh YS, Choe HN, Kong SH, Lee HJ, Kim WH, Yang HK.
Surg Endosc. 2014 Mar;28(3):789-95. doi: 10.1007/s00464-013-3256-1. Epub 2013 Nov 22.
Link